Jeffrey S. Eshleman

644 total citations
13 papers, 510 citations indexed

About

Jeffrey S. Eshleman is a scholar working on Radiology, Nuclear Medicine and Imaging, Genetics and Radiation. According to data from OpenAlex, Jeffrey S. Eshleman has authored 13 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Genetics and 5 papers in Radiation. Recurrent topics in Jeffrey S. Eshleman's work include Glioma Diagnosis and Treatment (5 papers), Advanced Radiotherapy Techniques (5 papers) and Medical Imaging Techniques and Applications (4 papers). Jeffrey S. Eshleman is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Advanced Radiotherapy Techniques (5 papers) and Medical Imaging Techniques and Applications (4 papers). Jeffrey S. Eshleman collaborates with scholars based in United States, United Kingdom and Germany. Jeffrey S. Eshleman's co-authors include Jann N. Sarkaria, Ann C. Mladek, Brett L. Carlson, Bernard F. King, Thomas M. Pisansky, Torrence M. Wilson, Brian J. Davis, Luther W. Brady, Curtis Miyamoto and Simin Dadparvar and has published in prestigious journals such as Cancer, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Jeffrey S. Eshleman

13 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey S. Eshleman United States	8	184	167	146	136	106	13	510
Danielle Gioioso United States	8	148 0.8×	119 0.7×	164 1.1×	124 0.9×	57 0.5×	13	440
Cyrus Amir United States	11	197 1.1×	184 1.1×	91 0.6×	254 1.9×	105 1.0×	14	652
Emma Song Australia	14	211 1.1×	129 0.8×	254 1.7×	102 0.8×	52 0.5×	18	564
Allan James United Kingdom	10	104 0.6×	79 0.5×	92 0.6×	164 1.2×	54 0.5×	30	433
Whoon Jong Kil United States	10	149 0.8×	134 0.8×	63 0.4×	137 1.0×	57 0.5×	28	430
C. A. Martindale United Kingdom	11	234 1.3×	155 0.9×	95 0.7×	147 1.1×	37 0.3×	15	531
Hooney Min United States	8	147 0.8×	123 0.7×	76 0.5×	108 0.8×	25 0.2×	15	377
Mao-Bin Meng China	13	169 0.9×	255 1.5×	73 0.5×	261 1.9×	100 0.9×	17	628
Willem DuBois United States	6	105 0.6×	129 0.8×	126 0.9×	141 1.0×	53 0.5×	7	373
Thuy Trinh Germany	11	194 1.1×	129 0.8×	97 0.7×	147 1.1×	22 0.2×	20	501

Countries citing papers authored by Jeffrey S. Eshleman

Since Specialization

Citations

This map shows the geographic impact of Jeffrey S. Eshleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Eshleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Eshleman more than expected).

Fields of papers citing papers by Jeffrey S. Eshleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey S. Eshleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Eshleman. The network helps show where Jeffrey S. Eshleman may publish in the future.

Co-authorship network of co-authors of Jeffrey S. Eshleman

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Eshleman. A scholar is included among the top collaborators of Jeffrey S. Eshleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Eshleman. Jeffrey S. Eshleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Eshleman, Jeffrey S., et al.. (2013). The Cyberknife ® M6 ™ Radiosurgery System. 2 indexed citations

2.

Eshleman, Jeffrey S., Brian J. Davis, Thomas M. Pisansky, et al.. (2004). Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: extraprostatic seed placement correlates with migration. International Journal of Radiation Oncology*Biology*Physics. 59(2). 419–425. 66 indexed citations

3.

Eshleman, Jeffrey S., et al.. (2002). Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy.. PubMed. 62(24). 7291–7. 166 indexed citations

4.

Sarkaria, Jann N. & Jeffrey S. Eshleman. (2001). ATM as a target for novel radiosensitizers. Seminars in Radiation Oncology. 11(4). 316–327. 46 indexed citations

5.

Eshleman, Jeffrey S., Brian J. Davis, Bernard F. King, et al.. (2001). Radioactive seed migration to the chest following transperineal interstitial prostate brachytherapy for early stage prostate carcinoma. International Journal of Radiation Oncology*Biology*Physics. 51(3). 297–298. 4 indexed citations

6.

Davis, Brian J., Eric A. Pfeifer, Torrence M. Wilson, et al.. (2000). PROSTATE BRACHYTHERAPY SEED MIGRATION TO THE RIGHT VENTRICLE FOUND AT AUTOPSY FOLLOWING ACUTE CARDIAC DYSRHYTHMIA. The Journal of Urology. 1661–1661. 3 indexed citations

7.

Eshleman, Jeffrey S., et al.. (2000). Does adjuvant radiotherapy for primary adenoid cystic carcinoma of the parotid gland reduce the risk for loco-regional recurrence and associated morbidity?. International Journal of Radiation Oncology*Biology*Physics. 48(3). 325–325. 1 indexed citations

8.

Davis, Brian J., Eric A. Pfeifer, Torrence M. Wilson, et al.. (2000). PROSTATE BRACHYTHERAPY SEED MIGRATION TO THE RIGHT VENTRICLE FOUND AT AUTOPSY FOLLOWING ACUTE CARDIAC DYSRHYTHMIA. The Journal of Urology. 164(5). 1661–1661. 54 indexed citations

9.

Emrich, Jacqueline, Hans Bender, Reiner Class, et al.. (1996). In Vitro Evaluation of Iodine-125-Labeled Monoclonal Antibody (MAb 425) in Human High-Grade Glioma Cells. American Journal of Clinical Oncology. 19(6). 601–608. 7 indexed citations

10.

Miyamoto, Curtis, Luther W. Brady, Michael Rackover, et al.. (1995). Utilization of ¹²⁵I monoclonal antibody in the management of primary glioblastoma multiforme. Radiation Oncology Investigations. 3(3). 126–132. 8 indexed citations

11.

Dadparvar, Simin, Curtis Miyamoto, Luther W. Brady, et al.. (1994). Indium-111-labeled anti-egfr-425 scintigraphy in the detection of malignant gliomas. Cancer. 73(S3). 884–889. 34 indexed citations

12.

Brady, Luther W., Curtis Miyamoto, David Woo, et al.. (1992). Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial. International Journal of Radiation Oncology*Biology*Physics. 22(1). 225–230. 118 indexed citations

13.

Rackover, Michael, Jeffrey S. Eshleman, David Woo, et al.. (1992). Utilization of the radiolabeled mab 425/emd 55 900 in the management of high grade gliomas. International Journal of Radiation Oncology*Biology*Physics. 24. 310–310. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact